Giant Biogene Holding Co., Ltd.

HKSE 2367.HK

Giant Biogene Holding Co., Ltd. Dividend Per Share for the year ending December 31, 2023: USD -0.00

Giant Biogene Holding Co., Ltd. Dividend Per Share is USD -0.00 for the year ending December 31, 2023, a -100.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
  • Giant Biogene Holding Co., Ltd. Dividend Per Share for the year ending December 31, 2022 was USD 0.05, a -86.75% change year over year.
  • Giant Biogene Holding Co., Ltd. Dividend Per Share for the year ending December 31, 2021 was USD 0.41, a 0.00% change year over year.
  • Giant Biogene Holding Co., Ltd. Dividend Per Share for the year ending December 31, 2020 was USD -0.00, a 0.00% change year over year.
  • Giant Biogene Holding Co., Ltd. Dividend Per Share for the year ending December 31, 2019 was USD -0.00.
Key data
Date Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE)
Market news
HKSE: 2367.HK

Giant Biogene Holding Co., Ltd.

CEO Mr. Jianya Yan
IPO Date Nov. 4, 2022
Location China
Headquarters No. 1855, Shanglin Yuan
Employees 1,512
Sector Health Care
Industries
Biotechnology Cosmetics Pharmaceuticals
Description

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.

StockViz Staff

January 15, 2025

Any question? Send us an email